Navigation Links
Ambit and Astellas Announce Results From Multiple Quizartinib Presentations at the 53rd Annual Meeting of the American Hematology Society
Date:12/13/2011

ients included in the analysis were either at least 60 years old and relapsed or refractory to first-line chemotherapy (Cohort 1, N=26), or at least 18 years old and relapsed or refractory to second-line chemotherapy or HSCT (Cohort 2, N=36).  The results from an earlier data cut of this patient subset were presented earlier this year at the European Hematology Association Meeting in London.  The study has now completed enrollment and results for the total study population are expected in 2012.

The co-primary end points of the study are composite complete remission (CRc) rate and complete remission (CR) rate in the first 84 days.  CRc is defined as the sum of complete remission, complete remission with incomplete platelet recovery (CRp), and complete remission with incomplete hematologic recovery (CRi).  In this updated interim analysis on 62 patients there were composite complete response (CRc) rates of 40 percent, 46 percent and 36 percent in all patients, Cohort 1 and Cohort 2, respectively.   The majority of CRc cases were CRi.  Notably, a CRc rate of 55 percent was achieved in patients who were refractory to the prior line of treatment (N=20).  Key secondary end points in the study include duration of remission, rates of partial response, and overall survival.  The median duration of response for patients achieving a CRc was 12.1, 14.3, and 10.1 weeks in all patients, Cohort 1 and Cohort 2, respectively, with patients censored at the time of transplant.  The median overall survival was 25.4, 24.1, and 26.9 weeks for all patients, Cohort 1, and Cohort 2, respectively.  An analysis of survival across all patients demonstrated that patients with a CRc had a 41 percent improved median survival versus non-responders, with durations of 34.1 and 24.2 weeks, respectively.

The most common treatment-related adverse events in the study included nausea, vomiting, fatigue and febrile neutropenia.  Sev
'/>"/>

SOURCE Ambit Biosciences
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. Ambit Biosciences Announces Transition in Company Leadership
3. Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia
4. Astellas Pharma Inc. to Acquire OSI Pharmaceuticals, Inc.
5. Astellas Awards Educational Scholarships to Six Transplant Recipients Who Embody the Spirit of Giving Back
6. Astellas Receives FDA Approval for Use of Prograf(R) (Tacrolimus) in Conjunction With Mycophenolate Mofetil (MMF) in Kidney Transplant Recipients
7. CV Therapeutics Board of Directors Rejects Astellas Tender Offer
8. CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas Tender Offer
9. CV Therapeutics Board of Directors Rejects Astellas Unsolicited Proposal
10. CV Therapeutics Statement on Unsolicited Proposal From Astellas
11. FDA Approves Astellas Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... , Aug. 1, 2014 Glencoe ... launch of "Data InPress" ( http://glencoesoftware.com/data-inpress.html ), ... integrating multidimensional image data into on-line publications.  ... and Video Injection Service. Photo ... http://photos.prnewswire.com/prnh/20140731/132409 The ...
(Date:7/31/2014)... August 01, 2014 “2014 ... Polyurethane Resin Industry” is a professional and ... The report introduces Polyurethane Resin basic information, ... chain structure and industry overview. This research ... domestic market as well as global industry ...
(Date:7/31/2014)... good reason people over 60 are not donor candidates ... weakens with time, making the elderly prone to life-threatening ... research team now has discovered a reason why. , ... inability of blood-forming cells to maintain blood production over ... defects that could be restored for rejuvenation therapies," said ...
(Date:7/31/2014)... sound-processing part of the mouse brain in a way ... in view. Their imaging technique allows zooming in and ... it enabled the team to watch brain cells light ... which represent a step toward better understanding how our ... journal Neuron . , In the past, researchers ...
Breaking Biology Technology:Glencoe Software Launches Data InPress 2Glencoe Software Launches Data InPress 3Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 2Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 3Polyurethane Resin Industry & Thermoplastic Polyurethane Market (China, Global) Analysis Now at DeepResearchReports.com 4Key to aging immune system is discovered 2New mapping approach lets scientists zoom in and out as the brain processes sound 2
... expanded access to choice, quality and cost-efficiency for patients ... Fla., June 24 Galichia Heart Hospital and Mobile ... to host MSI-coordinated, highly specialized, urologic surgical teams at ... Galichia,s capabilities as a center of excellence for selected ...
... 24 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: ... company focused on endocrine therapy and oncology, announced ... registered direct offering of US$10 million of units ... warrants to certain institutional investors. AEterna Zentaris received ...
... and diagnostics, including new technologies, enhanced biotech and drug developments, ... the center of Cleveland Clinic,s 7th Annual Medical Innovation Summit, ... more than 900 leaders from throughout the healthcare industry to ... and gain actionable insights. , , This year,s ...
Cached Biology Technology:Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM) 2Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM) 3AEterna Zentaris Receives US$10 Million from Institutional Investors 2AEterna Zentaris Receives US$10 Million from Institutional Investors 32009 Medical Innovation Summit at Cleveland Clinic to Highlight the Latest Developments in Cancer Care 22009 Medical Innovation Summit at Cleveland Clinic to Highlight the Latest Developments in Cancer Care 3
(Date:8/1/2014)... Service Provider Binary Biometrics is pleased to welcome Kevin Morris ... improve its mobile service capabilities and add more daily appointments, which will allow ... several new cities such as, but not limited to, Daytona Beach ... Deltona , Edgewater , Holly Hill ... , Oak Hill , Orange City ...
(Date:7/31/2014)... In the United States, natural-gas production from shale ... since 2007. Yet scientists still do not fully ... according to a report in the journal ... As gas extraction continues to vastly outpace scientific ... various organizations and institutions, including Princeton University, concluded ...
(Date:7/31/2014)... bigeye tuna movements in the northwestern Atlantic Ocean led ... Center at the University of Massachusetts Amherst, found among ... range with pronounced north-south movements from Georges Bank to ... off Cape Hatteras southwest of Bermuda for foraging. , ... study one of the most important commercial tuna species ...
Breaking Biology News(10 mins):Binary Biometrics, Founded by James Timothy White, Expands Services to 13+ Locations With the Addition of Owner/Operator Kevin Morris 2Binary Biometrics, Founded by James Timothy White, Expands Services to 13+ Locations With the Addition of Owner/Operator Kevin Morris 3'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 2'Fracking' in the dark: Biological fallout of shale-gas production still largely unknown 3Study of bigeye tuna in Northwest Atlantic uses new tracking methods 2Study of bigeye tuna in Northwest Atlantic uses new tracking methods 3
... the genome ?those that don't code for proteins ... regulate gene activity. Among those elements are microRNAs, ... expression. , Increasing evidence indicates a role for ... from Children's Hospital Boston now demonstrate that one ...
... rainforest puts on its biggest growth spurt during the dry ... , "Most of the vegetation around the world follows a ... the rainy season and then during the dry season, leaves ... support plant growth," said lead researcher Alfredo R. Huete of ...
... the use of letrozole, an easy-to-use and inexpensive ... be unfounded, according to a major study co–authored ... Reproductive Endocrinology and Infertility, McGill University Health Centre ... the Jewish General Hospital, and Professor of Obstetrics ...
Cached Biology News:Tiny RNA molecules fine-tune the brain's synapses 2Amazon rainforest greens up in the dry season 2Amazon rainforest greens up in the dry season 3Fertility drugs given 'all-clear' in new study 2
Recombinant Human PTP1B (aa 2-321), CF...
... This DuoSet ELISA Development kit contains the ... sandwich ELISAs to measure natural and recombinant ... and serum. Each kit contains sufficient materials ... plates, provided that the following conditions are ...
FGF Receptor 1 Antibody...
Immunogen: Purified native p24 from strain IIIB. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Biology Products: